Results from the largest ever individually randomised influenza vaccine effectiveness study

31 August 2025 (12:55 - 13:20)

Organised by:

Slides

Sign in to view the resources

About the speaker

Professor Tor Biering-Sorensen

Gentofte University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail

Opening remarks

Professor M. Volpe (Rome, IT)

Presentation thumbnail

A dose to support independence: evidence journey of high-dose influenza vaccine for older adults

Doctor M. Durusu Tanriover (Ankara, TR)

Presentation thumbnail

Q&A and closing remarks

Professor M. Volpe (Rome, IT) Professor T. Biering-Sorensen (Copenhagen, DK) Doctor M. Durusu Tanriover (Ankara, TR)

Access the full session

Session thumbnail

Protecting beyond infection: changing the FLU paradigm for older adults

The Event

Event poster

ESC Congress 2025

31 August 2025 12:55 CET

You may be interested in

Congress Presentation

DANFLU-2: High-Dose vs. Standard-Dose Influenza Vaccine and Cardio-Respiratory Outcomes in Older Adults

Congress Presentation

Effect of high-dose vs. standard-dose quadrivalent influenza vaccine on death and hospitalizations in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 study

Congress Presentation

The impact of Flu vaccine in patients with heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources